198 related articles for article (PubMed ID: 32157599)
1. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients.
Viglietta V; Shi F; Hu QY; Ren Y; Keilty J; Wolff H; McCarthy R; Kropp J; Weber P; Soglia J
Invest New Drugs; 2020 Oct; 38(5):1463-1471. PubMed ID: 32157599
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
Rolland V; Meyer F; Guitton MJ; Bussières R; Philippon D; Bairati I; Leclerc M; Côté M
J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):4. PubMed ID: 30651130
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.
Freyer DR; Chen L; Krailo MD; Knight K; Villaluna D; Bliss B; Pollock BH; Ramdas J; Lange B; Van Hoff D; VanSoelen ML; Wiernikowski J; Neuwelt EA; Sung L
Lancet Oncol; 2017 Jan; 18(1):63-74. PubMed ID: 27914822
[TBL] [Abstract][Full Text] [Related]
4. Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature.
Meijer AJM; Diepstraten FA; Ansari M; Bouffet E; Bleyer A; Fresneau B; Geller JI; Huitema ADR; Kogner P; Maibach R; O'Neill AF; Papadakis V; Rajput KM; Veal GJ; Sullivan M; van den Heuvel-Eibrink MM; Brock PR
J Clin Oncol; 2024 Jun; 42(18):2219-2232. PubMed ID: 38648563
[TBL] [Abstract][Full Text] [Related]
5. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
Brock PR; Maibach R; Childs M; Rajput K; Roebuck D; Sullivan MJ; Laithier V; Ronghe M; Dall'Igna P; Hiyama E; Brichard B; Skeen J; Mateos ME; Capra M; Rangaswami AA; Ansari M; Rechnitzer C; Veal GJ; Covezzoli A; Brugières L; Perilongo G; Czauderna P; Morland B; Neuwelt EA
N Engl J Med; 2018 Jun; 378(25):2376-2385. PubMed ID: 29924955
[TBL] [Abstract][Full Text] [Related]
6. Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial.
Duinkerken CW; de Weger VA; Dreschler WA; van der Molen L; Pluim D; Rosing H; Nuijen B; Hauptmann M; Beijnen JH; Balm AJM; de Boer JP; Burgers JA; Marchetti S; Schellens JHM; Zuur CL
Otol Neurotol; 2021 Jun; 42(5):678-685. PubMed ID: 33710154
[TBL] [Abstract][Full Text] [Related]
7. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
Madasu R; Ruckenstein MJ; Leake F; Steere E; Robbins KT
Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):978-81. PubMed ID: 9305250
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ototoxicity in patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin and sodium thiosulfate.
Womack AM; Hayes-Jordan A; Pratihar R; Barringer DA; Hall JH; Gidley PW; Lewin JS
Ear Hear; 2014; 35(6):e243-7. PubMed ID: 25127324
[TBL] [Abstract][Full Text] [Related]
9. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919
[TBL] [Abstract][Full Text] [Related]
10. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
11. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
13. Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey.
Orgel E; Freyer DR; Ullrich NJ; Hardy KK; Thomas SM; Dvorak CC; Esbenshade AJ
Pediatr Blood Cancer; 2020 Nov; 67(11):e28647. PubMed ID: 32886425
[TBL] [Abstract][Full Text] [Related]
14. Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.
Freyer DR; Brock PR; Chang KW; Dupuis LL; Epelman S; Knight K; Mills D; Phillips R; Potter E; Risby D; Simpkin P; Sullivan M; Cabral S; Robinson PD; Sung L
Lancet Child Adolesc Health; 2020 Feb; 4(2):141-150. PubMed ID: 31866182
[TBL] [Abstract][Full Text] [Related]
15. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
Crabb SJ; Martin K; Abab J; Ratcliffe I; Thornton R; Lineton B; Ellis M; Moody R; Stanton L; Galanopoulou A; Maishman T; Geldart T; Bayne M; Davies J; Lamb C; Popat S; Joffe JK; Nutting C; Chester J; Hartley A; Thomas G; Ottensmeier C; Huddart R; King E
Eur J Cancer; 2017 Dec; 87():75-83. PubMed ID: 29128692
[TBL] [Abstract][Full Text] [Related]
16. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
Neuwelt EA; Gilmer-Knight K; Lacy C; Nicholson HS; Kraemer DF; Doolittle ND; Hornig GW; Muldoon LL
Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
[TBL] [Abstract][Full Text] [Related]
17. First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate.
Neuwelt EA; Brummett RE; Doolittle ND; Muldoon LL; Kroll RA; Pagel MA; Dojan R; Church V; Remsen LG; Bubalo JS
J Pharmacol Exp Ther; 1998 Jul; 286(1):77-84. PubMed ID: 9655844
[TBL] [Abstract][Full Text] [Related]
18. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of sodium thiosulfate for cisplatin-mediated ototoxicity in patients with head and neck cancer.
Ishikawa E; Sugimoto H; Hatano M; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Murono S; Ito M; Yoshizaki T
Acta Otolaryngol; 2015 Sep; 135(9):919-24. PubMed ID: 25861690
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
